The impact of prenatal counselling on mothers of surviving children with hypoplastic left heart syndrome: A qualitative interview study.


Journal

Health expectations : an international journal of public participation in health care and health policy
ISSN: 1369-7625
Titre abrégé: Health Expect
Pays: England
ID NLM: 9815926

Informations de publication

Date de publication:
10 2020
Historique:
received: 24 11 2019
revised: 21 06 2020
accepted: 25 06 2020
pubmed: 17 7 2020
medline: 19 8 2021
entrez: 17 7 2020
Statut: ppublish

Résumé

To explore the role of antenatal counselling in how parents make treatment decisions following an antenatal diagnosis of Hypoplastic Left Heart Syndrome (HLHS). Antenatal counselling is a critical part of patient management following a diagnosis of fetal congenital heart disease; however, there is a very limited evidence base examining how parents actually experience antenatal counselling and make decisions in this context. Semi-structured interviews were conducted with women who had received an antenatal diagnosis of HLHS. Interviews were digitally recorded, anonymised and transcribed verbatim. A thematic content analysis was performed using a constant comparative approach. Eight mothers of surviving children with HLHS were interviewed. Eight key themes emerged including new perspectives on how women receive antenatal counselling and how it affects their decision making. Three themes in particular are new to the literature: (a) Mothers of children with HLHS reported feelings of intense guilt that arose in the antenatal period around potentially causing the condition in their child. (b) For this group of women, recollections of perceived pessimism during antenatal counselling had a lasting impact. (c) Despite support from partners or extended family, women nevertheless experienced a strong sense that antenatal decision making was largely a 'maternal' responsibility. When recounting their experiences of antenatal counselling, mothers of surviving children with HLHS offer new perspectives that can guide fetal cardiologists in how best to support their individual patients. Further research is needed to comprehensively understand the experience of prospective parents counselled for severe forms of fetal congenital heart disease.

Sections du résumé

OBJECTIVE
To explore the role of antenatal counselling in how parents make treatment decisions following an antenatal diagnosis of Hypoplastic Left Heart Syndrome (HLHS).
BACKGROUND
Antenatal counselling is a critical part of patient management following a diagnosis of fetal congenital heart disease; however, there is a very limited evidence base examining how parents actually experience antenatal counselling and make decisions in this context.
METHODS
Semi-structured interviews were conducted with women who had received an antenatal diagnosis of HLHS. Interviews were digitally recorded, anonymised and transcribed verbatim. A thematic content analysis was performed using a constant comparative approach.
RESULTS
Eight mothers of surviving children with HLHS were interviewed. Eight key themes emerged including new perspectives on how women receive antenatal counselling and how it affects their decision making. Three themes in particular are new to the literature: (a) Mothers of children with HLHS reported feelings of intense guilt that arose in the antenatal period around potentially causing the condition in their child. (b) For this group of women, recollections of perceived pessimism during antenatal counselling had a lasting impact. (c) Despite support from partners or extended family, women nevertheless experienced a strong sense that antenatal decision making was largely a 'maternal' responsibility.
CONCLUSIONS
When recounting their experiences of antenatal counselling, mothers of surviving children with HLHS offer new perspectives that can guide fetal cardiologists in how best to support their individual patients. Further research is needed to comprehensively understand the experience of prospective parents counselled for severe forms of fetal congenital heart disease.

Identifiants

pubmed: 32671929
doi: 10.1111/hex.13103
pmc: PMC7696135
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1224-1230

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© 2020 The Authors. Health Expectations published by John Wiley & Sons Ltd.

Références

Am J Bioeth. 2017 Jul;17(7):67-68
pubmed: 28661739
Pediatr Cardiol. 2014 Feb;35(2):239-52
pubmed: 23925415
Semin Fetal Neonatal Med. 2018 Feb;23(1):17-24
pubmed: 28917833
Adv Neonatal Care. 2010 Dec;10(6):316-22; quiz 323-4
pubmed: 21102175
J Clin Oncol. 2007 Jun 10;25(17):2414-9
pubmed: 17557955
Clin Perinatol. 2014 Dec;41(4):787-98
pubmed: 25459774
Pediatr Crit Care Med. 2013 Nov;14(9):869-75
pubmed: 23965635
BMC Pregnancy Childbirth. 2018 Jan 12;18(1):26
pubmed: 29329527
Arch Dis Child Fetal Neonatal Ed. 2013 Jan;98(1):F26-31
pubmed: 22732115
J Spec Pediatr Nurs. 2011 Jul;16(3):179-89
pubmed: 21702878
Cardiol Young. 2017 Mar;27(2):217-223
pubmed: 27821206
Health Expect. 2018 Jun;21(3):678-684
pubmed: 29392858
Congenit Heart Dis. 2013 Jan-Feb;8(1):78-85
pubmed: 22891764
J Obstet Gynecol Neonatal Nurs. 2004 Jan-Feb;33(1):64-70
pubmed: 14971554
Acta Paediatr. 2000 Sep;89(9):1129-33
pubmed: 11071097
Health Expect. 2020 Oct;23(5):1224-1230
pubmed: 32671929
J Perinatol. 2017 Jan;37(1):2-12
pubmed: 27513325
Arch Dis Child. 2017 May;102(5):468-471
pubmed: 27919885
Orphanet J Rare Dis. 2007 May 11;2:23
pubmed: 17498282
J Thorac Cardiovasc Surg. 2019 Jul;158(1):220-229
pubmed: 31248509
Cardiol Young. 2009 Apr;19(2):135-44
pubmed: 19272201
J Med Ethics. 2001 Apr;27(2):104-9
pubmed: 11314152
Semin Fetal Neonatal Med. 2018 Apr;23(2):150-154
pubmed: 29258838
Pediatr Cardiol. 2012 Dec;33(8):1402-10
pubmed: 22618584

Auteurs

Sophie Bertaud (S)

Department of Imaging Sciences and Biomedical Engineering, King's College London, Guy's and St Thomas' Hospital, London, UK.
Louis Dundas Centre for Children's Palliative Care, UCL Great Ormond Street Institute of Child Health, London, UK.

David F A Lloyd (DFA)

Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Gurleen Sharland (G)

Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Reza Razavi (R)

Department of Congenital Heart Disease, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.

Myra Bluebond-Langner (M)

Louis Dundas Centre for Children's Palliative Care, UCL Great Ormond Street Institute of Child Health, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH